NIH-funded research R21 grant

Finding drugs that help people with Alzheimer's disease stay mentally strong

Official title: Identify actionable drugs that enhance resilience in Alzheimer's disease individuals

Funded at University of Texas Hlth Sci Ctr Houston · NIH-11142599 · Data updated 2026-11-12

This study is looking for medications that can help people with Alzheimer's disease keep their thinking skills strong, using smart technology to understand how certain genes and biological processes work together.

More s Disease research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startAugust 1, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$195,000
NIH project number5R21AG087299-02
Project IDNIH-11142599 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Alzheimer's disease who exhibit cognitive resilience despite their condition.

Less likely to help

Patients with advanced Alzheimer's disease who have significant cognitive decline may not benefit from this research.

What this research studies

This research aims to identify drugs that can enhance cognitive resilience in individuals with Alzheimer's disease. By using advanced techniques like perturbation screening and artificial intelligence, the study will explore how certain genes and biological pathways contribute to maintaining cognitive function despite the presence of Alzheimer's-related conditions. The approach involves high-throughput profiling and computational modeling to uncover the interactions between various biological factors. Ultimately, the goal is to find actionable treatments that can help patients maintain their cognitive abilities.

Why it matters

Potential benefit: If successful, this research could lead to new drug therapies that help individuals with Alzheimer's disease preserve their cognitive function.

How similar studies have gone: Other research has shown promise in identifying resilience factors in neurological disorders, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Dai, Yulin — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Dai, Yulin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.